Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06680856Phase 1Completed

Allogeneic Platelet Rich Plasma (PRP) to Treat Diabetic Foot Ulcers

Role: collaborator

NCT04739228Not ApplicableCompleted

Effects of Guided Written Disclosure Protocol on Psychological Distress and Positive Functioning in Persons With Skin Diseases: a Randomized-controlled Trial

Role: collaborator

NCT03766243Not ApplicableCompleted

A Comparison Between Two Educational Methods in the Rehabilitation of the Microstomia in Systemic Sclerosis

Role: lead

All 3 trials loaded